Abstract | PURPOSE: METHODS: This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement ( PRISMA) and Meta-analysis Of Observational Studies in Epidemiology (MOOSE). Scopus, MEDLINE/PubMed, and Embase were searched electronically. RESULTS: CONCLUSION: There is limited evidence that PBM therapy is cost-effective in the prevention and treatment of specific cancer treatment-related toxicities, namely, OM and breast cancer-related lymphedema. Studies may have underreported the benefits due to a lack of a comprehensive cost evaluation. This suggests a wider acceptance of PBM therapy at cancer treatment centers, which has thus far been limited by the number of robust clinical studies that demonstrate cost-effectiveness for the prevention and treatment of toxicities.
|
Authors | Elisa Kauark-Fontes, Leticia Rodrigues-Oliveira, Joel B Epstein, Karina Morais Faria, Anna Luiza Damaceno Araújo, Luiz Alcino Monteiro Gueiros, Cesar Augusto Migliorati, Ramzi G Salloum, Patricia Burton, James Carroll, Marcio Ajudarte Lopes, Carolina Guimarães Bonfim Alves, Natalia Rangel Palmier, Ana Carolina Prado-Ribeiro, Thaís Bianca Brandão, Alan Roger Santos-Silva |
Journal | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
(Support Care Cancer)
Vol. 29
Issue 6
Pg. 2875-2884
(Jun 2021)
ISSN: 1433-7339 [Electronic] Germany |
PMID | 33411048
(Publication Type: Journal Article, Systematic Review)
|
Topics |
- Cost-Benefit Analysis
(methods)
- Humans
- Low-Level Light Therapy
(economics, methods)
- Neoplasms
(prevention & control, therapy)
|